Drug
doxorubicin hydrochloride liposome
Marketed as DOXORUBICIN HYDROCHLORIDE LIPOSOME.
Generic name
doxorubicin hydrochloride liposome
Brand names
DOXORUBICIN HYDROCHLORIDE LIPOSOME
First FDA approval
1995-11-17
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA050718 | DOXORUBICIN HYDROCHLORIDE LIPOSOME | 1995-11-17 | BAXTER HLTHCARE CORP |
Manufacturers
BAXTER HLTHCARE CORP
Frequently asked questions
When was doxorubicin hydrochloride liposome FDA approved?
Earliest FDA approval on record: 1995-11-17.
What brand names are sold as doxorubicin hydrochloride liposome?
DOXORUBICIN HYDROCHLORIDE LIPOSOME.
Sources
Appeal a doxorubicin hydrochloride liposome denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com